1. Home
  2. XENE vs GENI Comparison

XENE vs GENI Comparison

Compare XENE & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • GENI
  • Stock Information
  • Founded
  • XENE 1996
  • GENI 2016
  • Country
  • XENE Canada
  • GENI United Kingdom
  • Employees
  • XENE N/A
  • GENI N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • GENI Services-Misc. Amusement & Recreation
  • Sector
  • XENE Health Care
  • GENI Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • GENI Nasdaq
  • Market Cap
  • XENE 2.4B
  • GENI 2.4B
  • IPO Year
  • XENE 2014
  • GENI N/A
  • Fundamental
  • Price
  • XENE $31.75
  • GENI $10.61
  • Analyst Decision
  • XENE Strong Buy
  • GENI Strong Buy
  • Analyst Count
  • XENE 11
  • GENI 13
  • Target Price
  • XENE $54.82
  • GENI $12.12
  • AVG Volume (30 Days)
  • XENE 1.4M
  • GENI 5.4M
  • Earning Date
  • XENE 08-07-2025
  • GENI 08-05-2025
  • Dividend Yield
  • XENE N/A
  • GENI N/A
  • EPS Growth
  • XENE N/A
  • GENI N/A
  • EPS
  • XENE N/A
  • GENI N/A
  • Revenue
  • XENE $7,500,000.00
  • GENI $535,167,000.00
  • Revenue This Year
  • XENE N/A
  • GENI $23.92
  • Revenue Next Year
  • XENE $253.71
  • GENI $15.76
  • P/E Ratio
  • XENE N/A
  • GENI N/A
  • Revenue Growth
  • XENE N/A
  • GENI 22.89
  • 52 Week Low
  • XENE $26.74
  • GENI $5.29
  • 52 Week High
  • XENE $46.00
  • GENI $11.40
  • Technical
  • Relative Strength Index (RSI)
  • XENE 52.34
  • GENI 58.30
  • Support Level
  • XENE $31.11
  • GENI $9.38
  • Resistance Level
  • XENE $32.87
  • GENI $10.08
  • Average True Range (ATR)
  • XENE 1.23
  • GENI 0.45
  • MACD
  • XENE 0.16
  • GENI 0.10
  • Stochastic Oscillator
  • XENE 53.76
  • GENI 78.39

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About GENI Genius Sports Limited

Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.

Share on Social Networks: